MEDBOX | Toolbox Vaccine Candidates & Research

	FAQ COVID-19-Impfstoffe Entwicklung und Zulassung NEW Paul Ehrlich Institute (2021) CC Open external link (2) Add to my MEDBOX Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppe sowie zu Wechselwirkungen und Nebenwirkungen. Tags: Imfpung, COVID-19, SARS-CoV-2, Impfstoffe, Impfentwicklung, mRNA, Sicherheit, Risikogruppen, Nebenwirkungen, Source: https://www.pei.de/DE/newsroom/dossier/c
	Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca NEW Medicines and Healthcare products Regulatory Agency (MHRA) UK (2021) CC View PDF(0) Download (0) Add to my MEDBOX REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS Tags: UK, vaccine, Astra Zeneca, regulation, COVID-19, Source: https://assets.publishing.service.gov.uk
	Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020 Centers for Disease Control and Prevention CDC (2021) C_CDC View PDF(0) Download (0) Add to my MEDBOX Tags: Vaccination, side effects, SARS-CoV-2, mRNA, pfizer, COVID-19, Source: https://www.cdc.gov/mmwr/volumes/70/wr/p
	COVAX Initiative Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO (2021) C_WHO Open external link (4) Add to my MEDBOX COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world Tags: covax, vaccination, COVID-19, development, research, OneHealth, Access, Ethics, SARS-CoV-2, Source: https://www.who.int/initiatives/act-acce
	COVID-19 Vaccine Moderna European Medicines Agency EMA (2021) CC Open external link (4) Add to my MEDBOX Tags: vaccine, mRNA, Moderna, COVID-19, Source: https://www.ema.europa.eu/en/medicines/h
	Treatments and vaccines for COVID-19 European Medicines Agency EMA (2021) CC Open external link (24) Add to my MEDBOX The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the safety and effectiveness of medicines used in patients with COVID-19 Tags: Treatment, Drugs, Vaccines, COVID-19, research, safety, effectiveness, Source: https://www.ema.europa.eu/en/human-regul
	Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Polack, F.P. et al. (2020) CC Open external link (16) Add to my MEDBOX This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577 Tags: research paper, vaccine, COVID-19, mRNA, Source: https://www.nejm.org/doi/full/10.1056/NE
	Coronavirus Vaccine Tracker Zimmer, C, J. Corum and S. Wee New York Times (2020) CC Open external link (18) Add to my MEDBOX Accessed Dec. 14, 2020 Tags: vaccine, research, COVID-19, approval, development, Source: https://www.nytimes.com/interactive/2020
	COVID-19 vaccines World Health Organization WHO (2020) C_WHO Open external link (9) Add to my MEDBOX Tags: Vaccination, COVID-19, Strategy, accèss, IEC Material, resource platform, Source: https://www.who.int/emergencies/diseases
	Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document Pfizer; BioNTech (2020) C1 View PDF(159) Download (76) Add to my MEDBOX 10 December 2020 Tags: vaccine, candidates, mRNA, COVID-19, study protocol, Source: https://www.fda.gov/media/144246/downloa

About MEDBOX

MEDBOX Video Series